<div id="readability-page-1"><div><p><span>Sato Vicki L Chairman of the Board of Vir Biotechnology Inc [VIR] filed a Form 4 on December 2, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:</span></p><div><table><tbody><tr><td><span>Date</span></td><td><span>12/1/25</span></td></tr><tr><td><span>Transaction</span></td><td><span>Planned Sale(1)</span></td></tr><tr><td><span>Shares</span></td><td><span>22,000</span></td></tr><tr><td><span>Price</span></td><td><span>$6.00</span></td></tr><tr><td><span>Value</span></td><td><span>$132,070</span></td></tr></tbody></table></div><p><span>Ending Holdings: 1,188,391 - Direct</span></p><ul><li><span>(1)</span></li><li><span>Executed pursuant to a prearranged trading plan (10b5-1).</span></li></ul><p><span>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.</span></p><p><span>Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.</span></p><span> </span></div></div>

<p>Vicki L. Sato, Chairman of Vir Biotechnology Inc, sold 22,000 shares worth $132,070 on December 1, 2025, under a prearranged trading plan (10b5-1). Her direct holdings now total 1,188,391 shares.</p>

Chmn Sato Sells 22,000 ($132.1K) Of Vir Biotechnology Inc [VIR]